| __timestamp | AbbVie Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 7724000000 | 612613000000 |
| Thursday, January 1, 2015 | 6387000000 | 650773000000 |
| Friday, January 1, 2016 | 5855000000 | 619061000000 |
| Sunday, January 1, 2017 | 6275000000 | 628106000000 |
| Monday, January 1, 2018 | 7399000000 | 717599000000 |
| Tuesday, January 1, 2019 | 6942000000 | 964737000000 |
| Wednesday, January 1, 2020 | 11299000000 | 875663000000 |
| Friday, January 1, 2021 | 12349000000 | 886361000000 |
| Saturday, January 1, 2022 | 15260000000 | 997309000000 |
| Sunday, January 1, 2023 | 12872000000 | 1053819000000 |
| Monday, January 1, 2024 | 14752000000 | 1053819000000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, AbbVie Inc. and Takeda Pharmaceutical Company Limited have showcased contrasting trends in their SG&A expenditures. From 2014 to 2023, AbbVie Inc. saw a steady increase in SG&A expenses, peaking in 2022 with a 97% rise from 2016. In contrast, Takeda's SG&A expenses surged by approximately 72% from 2014 to 2023, reflecting its aggressive expansion strategy. Notably, Takeda's expenses in 2023 were nearly 10 times higher than AbbVie's, highlighting its significant market footprint. However, the absence of AbbVie's 2024 data suggests a potential shift or strategic realignment. This analysis underscores the importance of SG&A efficiency in driving profitability and competitive advantage in the pharmaceutical sector.
Gross Profit Comparison: AbbVie Inc. and Takeda Pharmaceutical Company Limited Trends
Selling, General, and Administrative Costs: AbbVie Inc. vs Biogen Inc.
AbbVie Inc. or Insmed Incorporated: Who Manages SG&A Costs Better?
AbbVie Inc. and BioMarin Pharmaceutical Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Opthea Limited
AbbVie Inc. vs ImmunityBio, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Merck & Co., Inc. vs Takeda Pharmaceutical Company Limited Trends and Insights
Breaking Down SG&A Expenses: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Takeda Pharmaceutical Company Limited or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Merus N.V.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Geron Corporation